HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Murata Selected Research

Carcinoma (Carcinomatosis)

6/2004Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
11/2001Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.
11/2001Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
11/2001Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
8/2001Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors.
1/2000Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Murata Research Topics

Disease

6Carcinoma (Carcinomatosis)
06/2004 - 01/2000
6Neoplasms (Cancer)
11/2001 - 01/2000
3Hyperthermia
06/2004 - 11/2001
3Necrosis
11/2001 - 01/2000
2Sarcoma (Soft Tissue Sarcoma)
11/2001 - 08/2001
2Leukemia
09/2001 - 05/2001
2Ischemia
07/2001 - 09/2000
1Multiple Myeloma
10/2017
1Residual Neoplasm
10/2017
1Shock
11/2007
1Pain (Aches)
09/2007
1Knee Osteoarthritis
09/2007
1Bronchiolitis Obliterans Syndrome
10/2002
1Pure Red-Cell Aplasia
10/2002
1Disseminated Intravascular Coagulation
09/2001
1Liver Diseases (Liver Disease)
07/2001
1Wounds and Injuries (Trauma)
07/2001
1Hypoglycemia (Reactive Hypoglycemia)
01/2001
1Subacute Sclerosing Panencephalitis (SSPE)
01/2001
1Febrile Seizures (Febrile Seizure)
01/2001
1Hyponatremia
01/2001
1Seizures (Absence Seizure)
01/2001
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2000
1Diverticulum
01/2000
1Hemorrhage
01/2000

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
11/2001 - 01/2000
3vadimezanIBA
06/2004 - 11/2001
3fosbretabulin (combretastatin A4)IBA
11/2001 - 01/2000
2Serotonin (5 Hydroxytryptamine)IBA
07/2001 - 09/2000
1LuciferasesIBA
11/2007
1SuspensionsIBA
11/2007
1Proteins (Proteins, Gene)FDA Link
11/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2007
1Dihydrotachysterol (AT 10)IBA
11/2001
1Dacarbazine (DIC)FDA LinkGeneric
09/2001
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
08/2001
1KetonesIBA
07/2001
1Serotonin ReceptorsIBA
07/2001
1AnthracyclinesIBA
05/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2001
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
05/2001
1flavone acetic acidIBA
01/2001
1Matrix-MIBA
01/2001
1Corticotropin-Releasing HormoneIBA
01/2001
1BariumIBA
01/2000
1Radioisotopes (Radionuclides)IBA
01/2000

Therapy/Procedure

1Stem Cell Transplantation
10/2017
1Extracorporeal Shockwave Therapy
09/2007
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
10/2002
1Intravenous Administration
07/2001
1Drug Therapy (Chemotherapy)
05/2001
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2000
1Leukocyte Transfusion
04/2000
1Therapeutics
01/2000